Sasilada Sirirungruang

Dr. Sasilada Sirirungruang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2024 in Nature
Verified
Journal Article
Open access
PDF file
YLYuzhong Liu
Yuzhong Liu
XZXixi Zhao
Xixi Zhao
Fei GanFei Gan
Fei Gan
XCXiaoyue Chen
Xiaoyue Chen
KDKai Deng
Kai Deng
JKJay D. Keasling
Jay D. Keasling
QS-21 is a potent vaccine adjuvant and remains the only saponin-based adjuvant that has been clinically approved for use in humans1,2. However, owing to the complex structure of QS-21, its availability is limited. Today, the supply depends on laborious extraction from the Chilean soapbark tree or on low-yielding total chemical synthesis3,4. Here we demonstrate the complete biosynthesis of QS-21 and its precursors, as well as structural derivatives, in engineered yeast strains. The successful biosynthesis in yeast requires fine-tuning of the host’s native pathway fluxes, as well as the functional and balanced expression of 38 heterologous enzymes. The required biosynthetic pathway spans seven enzyme families—a terpene synthase, P450s, nucleotide sugar synthases, glycosyltransferases, a coenzyme A ligase, acyl transferases and polyketide synthases—from six organisms, and mimics in yeast the subcellular compartmentalization of plants from the endoplasmic reticulum membrane to the cytosol. Finally, by taking advantage of the promiscuity of certain pathway enzymes, we produced structural analogues of QS-21 using this biosynthetic platform. This microbial production scheme will allow for the future establishment of a structure–activity relationship, and will thus enable the rational design of potent vaccine adjuvants.

28 February 2023 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
SSSasilada Sirirungruang
Sasilada Sirirungruang
CBCollin R. Barnum
Collin R. Barnum
STSophia N. Tang
Sophia N. Tang
PSPatrick Shih
Patrick Shih
This article highlights previous and prospective uses for plant glycosyltransferases in generating and diversifying bioactive glycosides, with implications in drug discovery applications.

11 July 2022 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
SSSasilada Sirirungruang
Sasilada Sirirungruang
OAOmer Ad
Omer Ad
TPThomas M. Privalsky
Thomas M. Privalsky
SRSwetha Ramesh
Swetha Ramesh
JSJoel L. Sax
Joel L. Sax
MCMichelle C. Y. Chang
Michelle C. Y. Chang

8 June 2022 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
SSSasilada Sirirungruang
Sasilada Sirirungruang
KMKasey Markel
Kasey Markel
PSPatrick Shih
Patrick Shih
This review provides a timely update on the needs for plant synthetic biology in expanding access to plant specialized metabolites. It discusses opportunities and technical challenges related to plant engineering and implementation.

10 July 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
SSSasilada Sirirungruang
Sasilada Sirirungruang
Vincent BlayVincent Blay
Vincent Blay
ERElys P. Rodriguez
Elys P. Rodriguez
YSYasmine F. Scott
Yasmine F. Scott
KVKhanh M. Vuu
Khanh M. Vuu
PSPatrick Shih
Patrick Shih
Plants have expanded various biosynthetic enzyme families to produce a wide diversity of natural products; however, most enzymes encoded in plant genomes remain uncharacterized, highlighting the need for new functional genomic approaches. Here, we report a platform enabling the rapid functional characterization of plant family 1 glycosyltransferases, which serve important roles in plant development, defense, and communication. Using substrate-multiplexed reactions, mass spectrometry, and automated analysis, we screen 85 enzymes against a diverse library of 453 natural products, for a total of nearly 40,000 possible reactions. The resulting dataset reveals a widespread promiscuity and a strong preference for planar, hydroxylated aromatic substrates among family 1 glycosyltransferases. We also characterize glycosyltransferases with an unusually wide substrate scope and with a non-canonical Cys-Asp catalytic dyad. This work establishes a widely-applicable enzymatic screening pipeline, reflects the immense glycosylation capability of plants, and has implications in biocatalysis, metabolic engineering, and gene discovery.

17 January 2024 in Plant Physiology
Verified
Journal Article
Open access
PDF file
KMKasey Markel
Kasey Markel
VNVlastimil Novak
Vlastimil Novak
BBBenjamin Bowen
Benjamin Bowen
YTYang Tian
Yang Tian
YCYi-Chun Chen
Yi-Chun Chen
PSPatrick Shih
Patrick Shih
Many insects have evolved the ability to manipulate plant growth to generate extraordinary structures called galls, in which insect larva can develop while being sheltered and feeding on the plant. In particular, cynipid (Hymenoptera: Cynipidae) wasps have evolved to form morphologically complex galls and generate an astonishing array of gall shapes, colors, and sizes. However, the biochemical basis underlying these remarkable cellular and developmental transformations remains poorly understood. A key determinant in plant cellular development is cell wall deposition that dictates the physical form and physiological function of newly developing cells, tissues, and organs. However, it is unclear to what degree cell walls are restructured to initiate and support the formation of new gall tissue. Here, we characterize the molecular alterations underlying gall development using a combination of metabolomic, histological, and biochemical techniques to elucidate how valley oak (Quercus lobata) leaf cells are reprogrammed to form galls. Strikingly, gall development involves an exceptionally coordinated spatial deposition of lignin and xylan to form de novo gall vasculature. Our results highlight how cynipid wasps can radically change the metabolite profile and restructure the cell wall to enable the formation of galls, providing insights into the mechanism of gall induction and the extent to which plants can be entirely reprogrammed to form unique structures and organs.